Nathan Cantoni

865 total citations
32 papers, 496 citations indexed

About

Nathan Cantoni is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Nathan Cantoni has authored 32 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 10 papers in Genetics and 8 papers in Immunology. Recurrent topics in Nathan Cantoni's work include Hematopoietic Stem Cell Transplantation (9 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and Acute Myeloid Leukemia Research (4 papers). Nathan Cantoni is often cited by papers focused on Hematopoietic Stem Cell Transplantation (9 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and Acute Myeloid Leukemia Research (4 papers). Nathan Cantoni collaborates with scholars based in Switzerland, United States and United Kingdom. Nathan Cantoni's co-authors include André Tichelli, Andreas Buser, Aloïs Gratwohl, Sabine Gerull, Dominik Heim, Jörg Halter, Christoph Bucher, Hans H. Hirsch, Martin Stern and Nina Khanna and has published in prestigious journals such as Blood, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Nathan Cantoni

31 papers receiving 483 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nathan Cantoni Switzerland	11	275	170	157	105	80	32	496
Sakhila Ghimire Germany	10	387 1.4×	109 0.6×	311 2.0×	157 1.5×	140 1.8×	20	692
Stephan Fuhrmann Germany	11	134 0.5×	120 0.7×	116 0.7×	110 1.0×	115 1.4×	18	398
Masatoshi Sakurai Japan	13	204 0.7×	93 0.5×	64 0.4×	118 1.1×	105 1.3×	69	497
Mohamad Sobh France	14	230 0.8×	102 0.6×	74 0.5×	131 1.2×	60 0.8×	61	476
Patricia Walker Australia	14	248 0.9×	81 0.5×	137 0.9×	144 1.4×	192 2.4×	54	628
Pınar Ataca Atilla Türkiye	9	200 0.7×	97 0.6×	65 0.4×	186 1.8×	36 0.5×	18	383
Fábio R. Kerbauy Brazil	11	291 1.1×	53 0.3×	87 0.6×	153 1.5×	48 0.6×	45	474
Marie Thérèse Rubio France	14	229 0.8×	47 0.3×	224 1.4×	182 1.7×	129 1.6×	39	561
Arancha Bermúdez Spain	9	212 0.8×	52 0.3×	64 0.4×	162 1.5×	95 1.2×	25	371
Steve Andresen United States	12	289 1.1×	52 0.3×	71 0.5×	183 1.7×	69 0.9×	30	524

Countries citing papers authored by Nathan Cantoni

Since Specialization

Citations

This map shows the geographic impact of Nathan Cantoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan Cantoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan Cantoni more than expected).

Fields of papers citing papers by Nathan Cantoni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathan Cantoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan Cantoni. The network helps show where Nathan Cantoni may publish in the future.

Co-authorship network of co-authors of Nathan Cantoni

This figure shows the co-authorship network connecting the top 25 collaborators of Nathan Cantoni. A scholar is included among the top collaborators of Nathan Cantoni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathan Cantoni. Nathan Cantoni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Condoluci, Adalgisa, Ilaria Romano, Daniel Dietrich, et al.. (2025). Ibrutinib lead-in followed by venetoclax plus ibrutinib for relapsed/refractory chronic lymphocytic leukemia: the SAKK 34/17 trial. Blood. 145(22). 2587–2598. 2 indexed citations

Gisslinger, Heinz, Valerio De Stefano, Vincenzo Accurso, et al.. (2023). Ruxolitinib in patients with polycythemia vera resistant and/or intolerant to hydroxyurea: European observational study. European Journal Of Haematology. 112(3). 379–391. 1 indexed citations

Khier, Sonia, Youssef Daali, Michael Medinger, et al.. (2023). Pharmacokinetic Modeling and Simulation with Pharmacogenetic Insights Support the Relevance of Therapeutic Drug Monitoring for Myeloablative Busulfan Dosing in Adult HSCT. Transplantation and Cellular Therapy. 30(3). 332.e1–332.e15. 4 indexed citations

Uppugunduri, Chakradhara Rao S., Michael Medinger, Joerg Halter, et al.. (2023). Effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with Busulfan. Bone Marrow Transplantation. 58(7). 811–816. 5 indexed citations

Schifferli, Alexandra, Alicia Rovó, Falk Nimmerjahn, et al.. (2023). Immunomodulation with romiplostim as a second‐line strategy in primary immune thrombocytopenia: The iROM study. British Journal of Haematology. 203(1). 119–130. 3 indexed citations

Joerger, Markus, Yannis Metaxas, Khalil Zaman, et al.. (2022). Outcome and Prognostic Factors of COVID-19 Infection in Swiss Cancer Patients: Final Results of SAKK 80/20 (CaSA). Cancers. 14(9). 2191–2191. 3 indexed citations

Cantoni, Nathan, et al.. (2022). A multicenter real-world evidence study in the Swiss treatment landscape of chronic myeloid leukemia. BMC Cancer. 22(1). 1192–1192. 3 indexed citations

Ribi, Karin, Solange Peters, Markus Borner, et al.. (2021). Pilot Testing of a Nurse-Led Basic Symptom Self-management Support for Patients Receiving First-Line Systemic Outpatient Anticancer Treatment. Cancer Nursing. 44(6). E687–E702. 5 indexed citations

Syedbasha, Mohammedyaseen, Hans‐Michael Kaltenbach, Nathan Cantoni, et al.. (2021). Association of Host Factors With Antibody Response to Seasonal Influenza Vaccination in Allogeneic Hematopoietic Stem Cell Transplant Patients. The Journal of Infectious Diseases. 225(8). 1482–1493. 4 indexed citations

10.

Medinger, Michael, Sabine Gerull, Joerg Halter, et al.. (2020). Busulfan-cyclophosphamide versus cyclophosphamide-busulfan as conditioning regimen before allogeneic hematopoietic cell transplantation: a prospective randomized trial. Annals of Hematology. 100(1). 209–216. 9 indexed citations

11.

Drexler, Beatrice, Jakob Passweg, Alexandar Tzankov, et al.. (2018). The sympathomimetic agonist mirabegron did not lower JAK2-V617F allele burden, but restored nestin-positive cells and reduced reticulin fibrosis in patients with myeloproliferative neoplasms: results of phase II study SAKK 33/14. Haematologica. 104(4). 710–716. 23 indexed citations

12.

Bonadies, Nicolas, Anita Feller, Alicia Rovó, et al.. (2017). Trends of classification, incidence, mortality, and survival of MDS patients in Switzerland between 2001 and 2012. Cancer Epidemiology. 46. 85–92. 24 indexed citations

13.

Benz, Rudolf, Jens Bremerich, Nathan Cantoni, et al.. (2017). Role of liver magnetic resonance imaging in hyperferritinaemia and the diagnosis of iron overload. Swiss Medical Weekly. 147(4546). w14550–w14550. 11 indexed citations

14.

Tzankov, Alexandar, Nathan Cantoni, Jörg Halter, et al.. (2012). Large Granular Lymphocyte Expansion after Allogeneic Hematopoietic Stem Cell Transplant Is Associated with a Cytomegalovirus Reactivation and Shows an Indolent Outcome. Biology of Blood and Marrow Transplantation. 18(11). 1765–1770. 22 indexed citations

15.

Janthur, Wolf-Dieter, Nathan Cantoni, & Christoph Mamot. (2012). Drug Conjugates Such as Antibody Drug Conjugates (ADCs), Immunotoxins and Immunoliposomes Challenge Daily Clinical Practice. International Journal of Molecular Sciences. 13(12). 16020–16045. 45 indexed citations

16.

Cantoni, Nathan, Hans H. Hirsch, Nina Khanna, et al.. (2010). Evidence for a Bidirectional Relationship between Cytomegalovirus Replication and acute Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 16(9). 1309–1314. 182 indexed citations

17.

Buser, Andreas, Nathan Cantoni, Sabine Gerull, et al.. (2010). Lymphocyte subset recovery and outcome after T-cell replete allogeneic hematopoietic SCT. Bone Marrow Transplantation. 46(10). 1357–1362. 53 indexed citations

18.

Cantoni, Nathan, Sabine Gerull, Dominik Heim, et al.. (2010). Order of application and liver toxicity in patients given BU and CY containing conditioning regimens for allogeneic hematopoietic SCT. Bone Marrow Transplantation. 46(3). 344–349. 26 indexed citations

19.

Cantoni, Nathan, Peter Meyer, Mira Katan, et al.. (2009). A confusing patient’s history: small or large vessel vasculitis?. Rheumatology International. 30(12). 1681–1683. 1 indexed citations

20.

Cantoni, Nathan, Maja Weisser, Andreas Buser, et al.. (2009). Infection prevention strategies in a stem cell transplant unit: impact of change of care in isolation practice and routine use of high dose intravenous immunoglobulins on infectious complications and transplant related mortality. European Journal Of Haematology. 83(2). 130–138. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact